Based in the United States, DeepSeq.AI is a startup. Brouky records 1 investor associated with the company.
DeepSeq.AI uses AI and hyperscaled protein interaction data to accelerate drug discovery by predicting molecular properties crucial for biologic drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.